Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Sarcoma, Kaposi × lenvatinib × Sarcoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 2 Recurrence 2 Osteosarcoma 2 Sarcoma, Kaposi 1 Rhabdomyosarcoma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neoplasms 1 Liposarcoma 1 Leiomyosarcoma 1 Glioma 1 GIST 1 Central Nervous System Neoplasms 1

Interventions

Doxorubicin 10 Zidovudine 7 Vincristine 7 Bleomycin 7 Nivolumab 5 Liposomes 5 Interferon alpha-2 5 pembrolizumab 4 liposomal doxorubicin 4 Semaxinib 4 Paclitaxel 4 Nelfinavir 4 Etoposide 4 tecogalan 3 pomalidomide 3 Specimen Handling 3 Ritonavir 3 Magnetic Resonance Spectroscopy 3 Filgrastim 3 Biopsy 3 Bevacizumab 3 technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran 2 sargramostim 2 interferon alfa-n1 2 Valganciclovir 2 Propranolol 2 Indinavir 2 Docetaxel 2 Didanosine 2 Daunorubicin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05846724 2026-01-22

PULSAR

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

Phase 2 Withdrawn

Sarcoma, Kaposi

Data powered by HemOnc (CC BY 4.0) Colophon ⚡